Foundation Fighting Blindness will provide up to $7.5 million in funding to develop ProQR’s candidate QR-421a for Usher syndrome type 2A

World News: . []

COLUMBIA Md and LEIDEN the Netherlands Feb 12 2018 GLOBE NEWSWIRE) -- Foundation Fighting Blindness and ProQR Therapeutics NV NASDAQPRQR today announced that they have entered into a partnership to develop QR-421a for Usher syndrome 2 A cause...

More news and information about ProQR Therapeutics N.V.; Foundation Fighting Blindness

Published By:

Globe Newswire: 12:00 GMT Monday 12th February 2018

Published: .

Search for other references to "foundation" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us